American National Group Inc.(ANG-PD)
Life & Health Insurance
Life Insurance
| Filing Date | Insider | Type | 10b5-1 | Net Shares | Ownership changeShares owned | Avg. Price | Value | Filing |
|---|---|---|---|---|---|---|---|---|
| 2023-10-02 | Lummus Dewayne SVP & Chief Accounting Officer | Purchase | +2 | +0.01%15,640 | $42.20 | $84 | View SEC filing | |
| 2023-09-29 | Lummus Dewayne SVP & Chief Accounting Officer | Purchase | +1,062 | +6.79%16,702 | $39.87 | $42,342 | View SEC filing | |
| 2023-09-25 | Lorenzen Jeffrey D Executive VP-Chief Inv Officer | Sale | -97,395 | -75.91%30,900 | $53.85 | $5,244,871 | View SEC filing | |
| 2023-09-22 | Andre Axel Chief Financial Officer | Sale | -29,273 | -66.79%14,553 | $53.87 | $1,577,062 | View SEC filing | |
| 2023-09-21 | Howe Robert L Director | Sale | -5,000 | -6.00%78,282 | $54.16 | $270,790 | View SEC filing | |
| 2023-09-21 | Bhalla Anant CEO & President | Sale | -183,202 | -15.12%1,028,134 | $54.05 | $9,901,207 | View SEC filing | |
| 2023-09-20 | Hamalainen James Louis EVP & Chief Investment Officer | Sale | -81,969 | -81.01%19,216 | $54.11 | $4,435,015 | View SEC filing | |
| 2023-09-20 | Bhalla Anant CEO & President | Sale | -168,935 | -6.91%1,028,134 | $54.12 | $9,142,725 | View SEC filing | |
| 2023-09-18 | Hamalainen James Louis EVP & Chief Investment Officer | Sale | -68,915 | -78.20%19,216 | $54.03 | $3,723,477 | View SEC filing | |
| 2023-08-17 | Howe Robert L Director | Sale | -5,000 | -5.66%83,282 | $53.35 | $266,750 | View SEC filing | |
| 2023-08-14 | Hamalainen James Louis EVP & Chief Investment Officer | Sale | -16,248 | -45.82%19,216 | $53.32 | $866,353 | View SEC filing | |
| 2023-03-24 | Matula Alan David Director | Purchase | +7,100 | +21.62%39,942 | $35.50 | $252,034 | View SEC filing | |
| 2022-08-11 | Lorenzen Jeffrey D EVP-Chief Risk Officer | Sale | -25,000 | -40.69%36,439 | $40.00 | $1,000,078 | View SEC filing | |
| 2022-05-18 | Neugent Gerard D. Director | Sale | -4,237 | -7.67%51,003 | $34.84 | $147,607 | View SEC filing | |
| 2022-04-14 | Grensteiner Ronald James Executive Vice President | Sale | -9,188 | -9.35%89,039 | $38.31 | $352,023 | View SEC filing | |
| 2022-03-16 | Grensteiner Ronald James Executive Vice President | Sale | -28,807 | -22.42%99,692 | $38.23 | $1,101,392 | View SEC filing | |
| 2022-03-11 | Chapman Joyce Ann Director | Sale | -3,856 | -6.99%51,279 | $38.26 | $147,548 | View SEC filing | |
| 2022-02-25 | Grensteiner Ronald James Executive Vice President | Sale | -10,894 | -8.83%112,509 | $36.03 | $392,487 | View SEC filing | |
| 2022-01-24 | Grensteiner Ronald James Executive Vice President | Sale | -10,894 | -7.84%128,103 | $42.05 | $458,087 | View SEC filing | |
| 2022-01-11 | Lorenzen Jeffrey D EVP-Chief Risk Officer | Sale | -20,000 | -28.81%49,414 | $41.10 | $821,969 | View SEC filing | |
| 2021-12-02 | Bhalla Anant CEO & President | Sale | -10,214 | -11.81%76,259 | $29.64 | $302,760 | View SEC filing | |
| 2021-06-23 | MATOVINA JOHN M Director | Sale | -4,200 | -2.97%137,124 | $32.26 | $135,495 | View SEC filing | |
| 2021-05-19 | Johnson Ted Morris Chief Financial Officer | Sale | -31,380 | -24.56%96,372 | $31.91 | $1,001,336 | View SEC filing | |
| 2021-05-14 | Howe Robert L Director | Sale | -6,143 | -8.71%64,357 | $30.01 | $184,380 | View SEC filing | |
| 2021-03-25 | Neugent Gerard D. Director | Sale | -6,281 | -14.11%38,219 | $29.36 | $184,438 | View SEC filing |
1-25 of 166